[PTX] YoY Quarter Result on 31-Dec-2012 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
31-Dec-2012
Financial Year
2013
Quarter
31-Dec-2012 [#Q2]
Profit Trend
QoQ- 477.80%
YoY- 477.80%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/01/12 31/01/11 31/01/10 CAGR
Revenue 712 31 0 0 0 0 0 -
PBT -623 -1,063 -1,186 1,787 -473 -357 -466 5.02%
Tax 47 -12 -427 0 36 -16 107 -12.97%
NP -623 -1,063 -1,186 1,787 -473 -340 -466 5.02%
Tax Rate - - - 0.00% - - - -
Total Cost 1,335 1,094 1,186 -1,787 473 340 466 19.46%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/01/12 31/01/11 31/01/10 CAGR
NP Margin -87.46 -3,413.87 -801,354.05 0.00 0.00 0.00 0.00 -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/01/12 31/01/11 31/01/10 CAGR
EPS -0.01 -0.02 -0.06 1.51 -0.41 -0.36 -0.59 -49.79%
EPS Diluted -0.01 -0.02 -0.06 1.51 -0.41 -0.36 -0.59 -49.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.